Top compounds associated with response to TIGD5


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.01
mRNA Axitinib GDSC1000 pan-cancer AAC 0.091 0.01
mRNA ABT-888 CTRPv2 pan-cancer AAC 0.094 0.01
mRNA Doxorubicin gCSI pan-cancer AAC -0.14 0.01
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.01
mRNA RG-108 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA KW-2449 CTRPv2 pan-cancer AAC 0.076 0.01
mRNA BRD-K75293299 CTRPv2 pan-cancer AAC 0.18 0.01
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.01
mRNA IPR-456 CTRPv2 pan-cancer AAC 0.094 0.01
Download CSV